Journal Article

Conditional expression of the mutant Ki-<i>ras</i><sup>G12C</sup> allele results in formation of benign lung adenomas: development of a novel mouse lung tumor model

Heather S. Floyd, Charles L. Farnsworth, Nancy D. Kock, Melissa C. Mizesko, Joy L. Little, Stephanie T. Dance, Jeff Everitt, Jay Tichelaar, Jeffrey A. Whitsett and Mark Steven Miller

in Carcinogenesis

Volume 26, issue 12, pages 2196-2206
Published in print December 2005 | ISSN: 0143-3334
Published online July 2005 | e-ISSN: 1460-2180 | DOI:
Conditional expression of the mutant Ki-rasG12C allele results in formation of benign lung adenomas: development of a novel mouse lung tumor model

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics


Show Summary Details


To determine the effects of expression of mutant Ki-ras on lung tumorigenesis, we developed a bitransgenic mouse model that expresses the human Ki-rasG12C allele in alveolar type II and/or Clara cells in a tetracycline-inducible, lung-specific manner. Expression of Ki-rasG12C caused multiple, small lung tumors over a 12-month time period. Although tumor multiplicity increased upon continued Ki-ras expression, most lung lesions were hyperplasias or well-differentiated adenomas. This is in contrast to the more severe phenotypes observed in other transgenic mouse models in which different mutant Ki-ras alleles were expressed in the lung. Expression of Ki-rasG12C was associated with a 2-fold increase in the activation of the Ras and Ral signaling pathways and increased phosphorylation of Ras downstream effectors, including Erk, p90 ribosomal S6 kinase, ribosomal S6 protein, p38 and MAPKAPK-2. In contrast, expression of the transgene had no effect on the activation of the JNK and Akt signaling pathways. Withdrawal of doxycycline for 1 month resulted in almost a complete absence of proliferative pulmonary lesions, suggesting tumor regression in the absence of Ki-ras expression. Mutant Ki-rasG12C expression was sufficient for initial lung tumor transformation, required for maintenance of tumor phenotype, and induced transformation of lung epithelial cells by the activation of multiple effector pathways. These results describe a novel mouse lung tumor model demonstrating benign tumor development in the absence of tumor progression, which will provide a new tool for understanding the early stages of lung tumor pathogenesis.

Keywords: AC, adenocarcinoma; AD, adenoma; CCSP, Clara cell secretory protein; DOX, doxycycline; Erk, extracellular regulated kinase; JNK, Jun kinase; MAPK, mitogen activated protein kinase; Mek, mitogen activated Erk kinase; RBD, Ras binding domain; RBP, Ral binding protein; rtTA, reverse tetracycline trans-activator; SP-C, surfactant protein C; tet, tetracycline

Journal Article.  9996 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.